Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Chemours Company (NYSE: CC) closed at $13.41 down -3.25% from its previous closing price of $13.86. In other words, the price has decreased by -$3.25 from its previous closing price. On the day, 2.69 million shares were traded.
Ratios:
For a deeper understanding of Chemours Company’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.68. In the meantime, Its Debt-to-Equity ratio is 7.21 whereas as Long-Term Debt/Eq ratio is at 7.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 28, 2025, initiated with a Buy rating and assigned the stock a target price of $27.
On July 09, 2024, UBS Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $28 to $30.
On June 07, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $25.Mizuho initiated its Neutral rating on June 07, 2024, with a $25 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when Scarborough Alvenia sold 7,500 shares for $20.64 per share. The transaction valued at 154,771 led to the insider holds 16,645 shares of the business.
Scarborough Alvenia bought 7,500 shares of CC for $150,000 on Nov 06 ’24. On Aug 07 ’24, another insider, Picho Diane I., who serves as the Interim Pres. – Titanium Tech of the company, sold 2,684 shares for $18.82 each. As a result, the insider received 50,519 and left with 19,890 shares of the company.
Valuation Measures:
As of this moment, Chemours’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.16, and their Forward P/E ratio for the next fiscal year is 4.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 3.32.
Stock Price History:
Over the past 52 weeks, CC has reached a high of $29.21, while it has fallen to a 52-week low of $13.77. The 50-Day Moving Average of the stock is -24.16%, while the 200-Day Moving Average is calculated to be -33.92%.
Shares Statistics:
A total of 149.43M shares are outstanding, with a floating share count of 148.72M. Insiders hold about 0.48% of the company’s shares, while institutions hold 84.89% stake in the company.
